Emily Bury: From Emerging Evidence to Better Patient Care at ISTH 2026
Emily Bury, Advanced Nurse Practitioner for Thrombosis at St.Vincent’s Healthcare Group, shared a post on LinkedIn:
“A fantastic few days at ISTH 2026 in Paris, with rich learning, inspiring discussions and valuable opportunities to connect with colleagues from around the world.
It was exciting to see women’s health take centre stage, including the launch of the ‘Women’s Health Hub‘—a significant step towards advancing research, education and equitable care for women with thrombosis and bleeding disorders.
Another key highlight was the continued focus on ‘cancer-associated VTE‘, with the ‘API-CAT trial‘ demonstrating that extended treatment with ‘reduced-dose apixaban’ was non-inferior to the full treatment dose for preventing recurrent VTE, while reducing clinically relevant bleeding.
Delighted to attend alongside Tracy Egan of the Irish Heart Foundation – (supporting Thrombosis patients).
Looking forward to bringing insights from ISTH back to support better patient care.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026